Editorial

Ulevitch RJ Recognition of bacterial endotoxins by receptor-dependent mechanisms. Adv Immunol 1993; 53: 267-289.

Morrison DC , Danner RL , Dinarello CA et al. Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future directions. J Endotoxin Res 1994; 1: 71-83.

Bone RC Gram-negative sepsis: a dilemma of modem medicine. Clin Microbiol Rev 1993; 6: 57-68.

Cross AS , Opal S. Therapeutic intervention in sepsis with antibody to endotoxin: is there a future? J Endotoxin Res 1994; 1: 57-69.

Dinarello CA , Gelfand JA , Wolff SM Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA 1993; 269: 1829-1835.

Wherry J. , Wenzel R. , Wunderink R. et al. Monoclonal antibody to human TNF: multicenter efficacy and safety study in patients with sepsis syndrome. Abstract 33rd ICAAC, New Orleans, LA, USA, 1994; p. 246.

Fisher Jr CH , Dhainaut JF , Opal SM , Pribble JP , Balk RA , Slotman GJ Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. JAMA 1994; 271: 1836-1843.